[ORGANIZATION]
Remibrutinib
Featured in 3 tracked stories · first seen
Situations
Novartis remibrutinib Phase III clinical trial results
2 clusters · 14 sources · last updated
Latest: Novartis reports positive Phase III results for oral MS drug remibrutinib
Novartis has reported positive topline results from two Phase III clinical trials, REMODEL-1 and REMODEL-2, evaluating its experimental oral drug remibrutinib for the treatment of relapsing multiple sclerosis. The drug,
Also covered in
-
Yuhan Corporation and Novartis Korea partner to distribute Remibrutinib
[BUSINESS] · 2 sources ·